Bioxyne Limited (ASX:BXN)

1.9¢

right-arrow Created with Sketch. -0.003 (-13.64%)
MCAP $12.16M
Last trade 10.59am 26/11/2021 20mins delayed

Latest Announcements

04/11/2021 Price SensitivePSBXNBioxyne Limited
04/11/2021 Price SensitivePSBXNBioxyne Limited
29/10/2021BXNBioxyne Limited
29/10/2021BXNBioxyne Limited
29/10/2021 Price SensitivePSBXNBioxyne Limited
28/10/2021 Price SensitivePSBXNBioxyne Limited
27/10/2021 Price SensitivePSBXNBioxyne Limited
856
MCap
27/10/2021 Price SensitivePSBXNBioxyne Limited
459
MCap

Company Overview

Bioxyne Limited is an Australia-based bio-technology company. The Company is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company operates through two segments wholesale sales and direct sales. The Company manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The Company is focusing on developing a range of functional food and beauty products.

BXN in the news

Science research company Bioxyne, has had a positive September quarter, reporting strong…

Search Previous Announcements